skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: Milner Therapeutics Institute: a drug discovery ecosystem

Milner Therapeutics Institute: a drug discovery ecosystem

30 June 2017

Professor Tony Kouzarides is passionate about ecosystems: well-balanced communities that flourish on mutual and dynamic interactions. But the ecosystems that excite him are not made up of plants, animals and environments. They’re made up of experts. Kouzarides is the founding Director of the Milner Therapeutics Institute...


Read more at: Drugs: how to pick a winner in clinical trials

Drugs: how to pick a winner in clinical trials

29 June 2017

When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an ‘adaptive’ approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner. “ Did not meet primary...


Read more at: How to train your drugs: from nanotherapeutics to nanobots

How to train your drugs: from nanotherapeutics to nanobots

28 June 2017

Nanotechnology is creating new opportunities for fighting disease – from delivering drugs in smart packaging to nanobots powered by the world’s tiniest engines. One way that researchers are attempting to improve the safety and efficacy of drugs, such as those used to treat cancer, is to use a relatively new area of...


Read more at: Computer-designed antibodies target toxins associated with Alzheimer’s disease

Computer-designed antibodies target toxins associated with Alzheimer’s disease

26 June 2017

Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production. Alzheimer’s disease is the most common form of dementia, which affects nearly one million people in the UK and about 50 million worldwide. One of...


Read more at: The bug hunters and the microbiome

The bug hunters and the microbiome

26 June 2017

Dr Trevor Lawley and Professor Gordon Dougan are bug hunters, albeit not the conventional kind. The bugs they collect are invisible to the naked eye. And even though we’re teeming with them, researchers are only beginning to discover how they keep us healthy – and how we could use these bugs as drugs. Both researchers lead...


Read more at: Apollo's mission to drive therapeutic innovation

Apollo's mission to drive therapeutic innovation

21 June 2017

The stirrings of a revolution are starting to ripple through hundreds of laboratories. It’s a revolution that aims to result in new medicines – faster and with fewer failures – and it’s being led by three UK universities and three global pharmaceutical companies. In January 2016, the tech transfer offices (TTOs) of...


Read more at: Patching up a broken heart

Patching up a broken heart

21 June 2017

It is almost impossible for an injured heart to fully mend itself. Within minutes of being deprived of oxygen – as happens during a heart attack when arteries to the heart are blocked – the heart’s muscle cells start to die. Dr Sanjay Sinah leads a team of stem cell biologists in the Cambridge Stem Cell Institute. Over the...


Read more at: Cambridge start-up raises £40 million in funding to develop new cancer treatments

Cambridge start-up raises £40 million in funding to develop new cancer treatments

21 June 2017

Cambridge-based start-up Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials. The company is developing a new class of drugs called ‘Bicycles’, which are based on small protein chains, or peptides, which have been chemically constrained, and...


Read more at: Take your medicine: how research into supply chains will help you take care of yourself

Take your medicine: how research into supply chains will help you take care of yourself

15 June 2017

Researchers are working with pharmaceutical companies to make improvements across the whole supply chain, from how a pill is made to the moment it is swallowed by the patient. Dr Jag Srai, Head of the Centre for International Manufacturing at the University of Cambridge's Institute for Manufacturing (IfM) talked to...


Read more at: Future therapeutics: the hundred-year horizon scan

Future therapeutics: the hundred-year horizon scan

13 June 2017

How will precision medicine define 21st-century therapeutics? What will future healthcare look like? And what actually lies ‘beyond the pill’? In the latest edition of Research Horizons Professor Chris Lowe, Director of the Cambridge Academy of Therapeutic Sciences, takes the long view on the future of therapeutics...